1. Krakvik, B., Grawe, R., Hagen, R., Stiles, T., “Cognitive Behaviour Therapy for Psychotic Symptoms: A Randomized Controlled Effectiveness Trial” US National Library of Medicine [Internet] 2013 Mar [cited 2019 Nov]
2. Amminger, Schafer, Papageorgiou, Klier, Cotton, Harrigan, MacKinnon, McGorry, Berger, “Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial” US National Library of Medicine [Internet] 2010 Feb [cited 2019 Nov]
3. APA Div 12, Society of Clinical Psychology, “What is Exposure Therapy?” Clinical Practice Guidelines, [Internet] 2017 Jul [cited 2020 Aug 13]
4. “Antipsychotics- What if I don’t want to take antipsychotics?” Information letter published by MIND For Better Health [Internet] 2016 [cited 2020 Aug 13]
5. Sathyanarayana Rao TS, Asha MR, Ramesh BN, Jagannatha Rao, “Understanding nutrition, depression, and mental illness.” Indian Journal of Psychiatry [Internet] 2008 Apr-Jun [cited 2020 Aug 13]
6. PACHECO A, EASTERLING WS, PRYER MW. A PILOT STUDY OF THE KETOGENIC DIET IN SCHIZOPHRENIA. Am J Psychiatry. 1965 May;121:1110-1. doi: 10.1176/ajp.121.11.1110. PMID: 14283310. [cited 2020 Dec 28]
7. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD Lauren V. Moran, M.D., Dost Ongur, M.D., Ph.D., John Hsu, M.D., M.S.C.E., Victor M. Castro, M.S., Roy H. Perlis, M.D., and Sebastian Schneeweiss, M.D., Sc.D. March 21, 2019 N Engl J Med 2019; 380:1128-1138 DOI: 10.1056/NEJMoa1813751. [cited 2020, Dec 28]
8. Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8. PMID: 25373627; PMCID: PMC5027896. [cited 2020 Dec 28]
9. Wang P, Si T. Use of antipsychotics in the treatment of depressive disorders. Shanghai Arch Psychiatry. 2013;25(3):134-140. doi:10.3969/j.issn.1002-0829.2013.03.002. [cited 2020 Dec 28]
10. Williams HJ, Owen MJ, O’Donovan MC. Is COMT a susceptibility gene for schizophrenia?. Schizophr Bull. 2007;33(3):635-641. doi:10.1093/schbul/sbm019. [cited 2020 Dec 28]
11. Ira E, Zanoni M, Ruggeri M, Dazzan P, Tosato S. COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation. J Psychiatry Neurosci. 2013;38(6):366-380. doi:10.1503/jpn.120178. [cited 2020 Dec 28]
12. Acute Hypoglycemia Presenting as Acute Psychosis Tanveer Padder MD, Aparna Udyawar MD, Nouman Azhar MD, Kamil Jaghab MD From the Department of Psychiatry, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow NY 11554 USA.First Published December 2005. [cited 2020 Dec 28]
13. Brady WJ Jr, Duncan CW. Hypoglycemia masquerading as acute psychosis and acute cocaine intoxication. Am J Emerg Med. 1999 May;17(3):318-9. doi: 10.1016/s0735-6757(99)90140-7. PMID: 10337905. [cited 2020 Dec 28]
14. Cannabis-Induced Psychosis: A Review Psychiatric Times, Vol 34 No 7, Volume 34, Issue 7July 14, 2017 Ruby S. Grewal, MD , Tony P. George, MD, FRCPC. [cited 2020 Dec 28]
15. Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jørgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry. 2005 Dec;187:510-5. doi: 10.1192/bjp.187.6.510. PMID: 16319402. [cited 2020 Dec 28]
16. Rottanburg D, Robins AH, Ben-Arie O, Teggin A, Elk R. Cannabis-associated psychosis with hypomanic features Lancet. 1982 Dec 18;2(8312):1364-6. doi: 10.1016/s0140-6736(82)91270-3. PMID: 6129463. [cited 2020 Dec 28]
17. Understanding nutrition, depression and mental illnesses Indian J Psychiatry. 2008 Apr-Jun; 50(2): 77–82. T. S. Sathyanarayana Rao, M. R. Asha, B. N. Ramesh, and K. S. Jagannatha Rao [cited 2020 Dec 28]
18. Environmental Exposures and Depression: Biological Mechanisms and Epidemiological Evidence Annual Review of Public Health Vol. 40:239-259 (Volume publication date April 2019) First published as a Review in Advance 2019 Jan 11 [cited 2020 Dec 28]
19. Health Quality Ontario . Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment. Ont Health Technol Assess Ser. 2018;18(5):1-141. Published 2018 Oct 24. [cited 2020 Dec 28]
20. Seikkula J, Olson ME. The open dialogue approach to acute psychosis: its poetics and micropolitics. Fam Process. 2003 Fall;42(3):403-18. doi: 10.1111/j.1545-5300.2003.00403.x. PMID: 14606203. [cited 2020 Dec 28]
21. van den Berg DP, de Bont PA, van der Vleugel BM, de Roos C, de Jongh A, Van Minnen A, van der Gaag M. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833. [cited 2020 Dec 28]
22. Mental Health Medications National Institute of Mental Health Last Revised: October 2016 [cited 2020 Dec 29]
23. Better Off Without Antipsychotic Drugs? June 18, 2014 E. Fuller Torrey, MD Psychiatric Times, Vol 31 No 6, Volume 31, Issue 6 [cited 2020 Dec 29]
24. Long-term Prognosis and Followup in Schizophrenia Joseph H. Stephens Author Notes Schizophrenia Bulletin, Volume 4, Issue 1, 1978, Pages 25–47, Published: 01 January 1978. [cited 2020 Dec 29]
25. Psychosocial Intervention With or Without Antipsychotic Medication for First-Episode Psychosis: A Randomized Noninferiority Clinical Trial
Shona M Francey, Brian O’Donoghue, Barnaby Nelson, Jessica Graham, Lara Baldwin, Hok Pan Yuen, Melissa J Kerr, Aswin Ratheesh, Kelly Allott, Mario Alvarez-Jimenez Schizophrenia Bulletin Open, Volume 1, Issue 1, January 2020, Published: 20 March 2020. [cited 2020 Dec 29]
26. Hoffer A, Osmond H. TREATMENT OF SCHIZOPHRENIA WITH NICOTINIC ACID. A TEN YEAR FOLLOW-UP. Acta Psychiatr Scand. 1964;40(2):171-89. doi: 10.1111/j.1600-0447.1964.tb05744.x. PMID: 14235254. [cited 2020 Dec 29]
27. Department of Psychiatry UC San Diego School of Medicine Preparing Open Dialogue Approach for Implementation in the U.S. [cited 2020 Dec 29]
28. Antipsychotics: Taking the Long View National Institute of Mental Health By Former NIMH Director Thomas Insel on August 28, 2013 [cited 2020 Dec 29]
29. Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutr J. 2008;7:2. Published 2008 Jan 21. doi:10.1186/1475-2891-7-2 [cited 2020 Dec 29]
30. Kraal A, Z, Arvanitis N, R, Jaeger A, P, Ellingrod V, L: Could Dietary Glutamate Play a Role in Psychiatric Distress? Neuropsychobiology 2020;79:13-19. doi: 10.1159/000496294 [cited 2020 Dec 29]
31. Plitman E, Nakajima S, de la Fuente-Sandoval C, et al. Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur Neuropsychopharmacol. 2014;24(10):1591-1605. doi:10.1016/j.euroneuro.2014.07.015. [cited 2020 Dec 29]
32. van der Heijden, F., Fekkes, D., Tuinier, S. et al. Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?. J Neural Transm 112, 577–585 (2005). [cited 2020 Dec 29]
33. Acta Psychiatrica Scandinavica Fat consumption and schizophrenia O. Christensen M.D., E. Christensen First published: November 1988. [cited 2020 Dec 29]
34. Malcolm Peet, Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results, Prostaglandins, Leukotrienes and Essential Fatty Acids, Volume 69, Issue 6, 2003, Pages 477-485. [cited 2020 Dec 29]
35. Leonardo Tondo, Nereide Rudas, The course of a seasonal bipolar disorder influenced by caffeine, Journal of Affective Disorders, Volume 22, Issue 4, 1991, Pages 249-251. [cited 2020 Dec 29]
36. Environmental Exposures and Depression: Biological Mechanisms and Epidemiological Evidence Annual Review of Public Health Vol. 40:239-259 (Volume publication date April 2019) First published as a Review in Advance on 2019 Jan 11 [cited 2020 Dec 29]
37. Mittal VA, Vargas T, Osborne KJ, et al. Exercise Treatments for Psychosis: A Review. Curr Treat Options Psychiatry. 2017;4(2):152-166. doi:10.1007/s40501-017-0112-2.[cited 2020 Dec 29]
38. Collaborative on Mental Health and the Environment Mental Health and Environmental Exposures from the Learning and Developmental Disabilities Initiative, November 2008. [cited 2020 Dec 29]
39. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study Published online by Cambridge University Press: 24 March 2014 M. Harrow, T. H. Jobe and R. N. Faull. [cited 2020 Dec 29]
40. A psychiatrist thinks some patients are better off without antipsychotic drugs Washington Post By Sandra Steingard December 9, 2013 [cited 2020 Dec 29]
41. Antipsychotic Drugs, Their Harmful Effects, and the Limits of Tort Reform Huffpost By Peter R. Breggin M.D. 11/01/2009 02:18pm EST | Updated November 17, 2011. [cited 2020 Dec 30]
42. Tost H, Alam T, Meyer-Lindenberg A. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev. 2010;34(5):689-700. doi:10.1016/j.neubiorev.2009.06.005. [cited 2020 Dec 30]
43. Know your brain: Reward system Neuroscientifically Challenged January 16, 2015. [cited 2020 Dec 30]
44. A H Ashok, T R Marques, S Jauhar, M M Nour, M Goodwin, A H Young, and O D Howes. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment Mol Psychiatry. 2017 May; 22(5): 666–679. Published online 2017 Mar 14. doi: 10.1038/mp.2017.16 [cited 2020 Dec 30]
45. Bové J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson’s disease. NeuroRx. 2005;2(3):484-494. doi:10.1602/neurorx.2.3.484 [cited 2020 Dec 30]
46. Farina M, Aschner M, da Rocha JBT. The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity. Adv Neurotoxicol. 2017;1:47-81. doi:10.1016/bs.ant.2017.07.002 [cited 2020 Dec 30]
47. The Relationship Between Genetics and Detox (It’s all about Methylation!) November 16, 2016. by Dr. B.J. Hardick [cited 2020 Dec 30]
48. Orthomolecular Treatment of Orthomolecular Schizophrenia Association of Great Britain; London, England, September 28-30, 1971. A. Hoffer, M.D., Ph.D., F.A.P.A. [cited 2020 Dec 30]